David Gionco
Overview
David Gionco received an average of $1M in total compensation, including $258K in salary, at Stemline Therapeutics from 2013 to 2019.
2019Stemline TherapeuticsSenior Vice President of Finance and Chief Accounting Officer
2018Stemline TherapeuticsVice President of Finance and Chief Accounting Officer
2017Stemline TherapeuticsVice President of Finance and Chief Accounting Officer
2016Stemline TherapeuticsVice President of Finance and Chief Accounting Officer
2015Stemline TherapeuticsVice President of Finance and Chief Accounting Officer
2014Stemline TherapeuticsVice President of Finance and Chief Accounting Officer
2013Stemline TherapeuticsVice President of Finance and Chief Accounting Officer
Source: SEC filings on April 29, 2020, April 30, 2019, April 30, 2018, May 1, 2017, and April 8, 2016.
Related executives
We found six more executives who work or worked at Stemline Therapeutics.
Ivan Bergstein
Stemline Therapeutics
Chief Executive Officer
Kenneth Hoberman
Stemline Therapeutics
Chief Operating Officer
Robert Francomano
Stemline Therapeutics
Chief Commercial Officer
Eric Rowinsky
Stemline Therapeutics
Chief Medical Officer
Stephen Hall
Stemline Therapeutics
Chief Accounting Officer
John Cavan
Stemline Therapeutics